Athira Pharma, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ATHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
18706 North Creek Parkway, Suite 104, Bothell, WA

Insiders trading volume in the past year

Athira Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc Director, 10%+ Owner $12.9M Dec 27, 2023
Glenna Mileson Chief Financial Officer $465K Jan 19, 2023
Hans Moebius Chief Medical Officer $266K Jan 4, 2024
Mark James Litton President and CEO, Director $226K -$21.5K -8.69% Jun 30, 2025
Kelly A. Romano Director $195K May 30, 2025
Kevin Church Chief Scientific Officer $82.5K -$7.28K -8.11% Jun 30, 2025
Mark Worthington General Counsel and CCO $65K -$7.28K -10.1% Jun 30, 2025
Javier San Chief Medical Officer $62.7K -$9.27K -12.9% Jun 30, 2025
Andrew Gengos CFO and Chief Business Officer $55.2K Sep 3, 2024
Robert Renninger SVP, Finance and Accounting $54K -$2.47K -4.38% Jun 30, 2025
Rachel Lenington COO and CDO $11.8K Sep 3, 2024
Joseph Edelman Director May 30, 2025
Barbara Kosacz Director May 30, 2025
John M. Fluke Jr Director May 30, 2025
James A. Johnson Director May 30, 2025
Grant Pickering Director May 30, 2025
Tadataka Yamada Director May 28, 2021
Michael A. Panzara Director May 30, 2025

Recent Insider Transactions by Companies or Individuals for Athira Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.